Jilin Province Huinan Changlong Bio-pharmacy Co (FRA:JIL) Margin of Safety % (DCF Earnings Based): 50.40% (As of Jul. 05, 2026)


FRA:JIL Jilin Province Huinan Changlong Bio-pharmacy Co Ltd FRA:JIL
81 GF Score
Price €0.25
GF Value €0.18
! 1 Warning Sign
View Full Analysis

What is Jilin Province Huinan Changlong Bio-pharmacy Co Margin of Safety % (DCF Earnings Based)?

Jilin Province Huinan Changlong Bio-pharmacy Co FRA:JIL 81 Margin of Safety % (DCF Earnings Based) is 50.40% as of Jul. 05, 2026. GuruFocus rates FRA:JIL with a GF Score™ of 81/100 and a GF Value™ of €0.18. The stock has 1 warning sign investors should review.

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

As of today (2026-07-05), Jilin Province Huinan Changlong Bio-pharmacy Co's Predictability Rank is 2.5-Stars. Jilin Province Huinan Changlong Bio-pharmacy Co's intrinsic value calculated from the Discounted Earnings model is €0.50 and current share price is €0.248. Consequently,

Jilin Province Huinan Changlong Bio-pharmacy Co's Margin of Safety % (DCF Earnings Based) using Discounted Earnings model is 50.40%.

FRA:JIL vs ZTS, UTHR: Margin of Safety % (DCF Earnings Based) Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Jilin Province Huinan Changlong Bio-pharmacy Co's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Jilin Province Huinan Changlong Bio-pharmacy Co Margin of Safety % (DCF Earnings Based) vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Jilin Province Huinan Changlong Bio-pharmacy Co's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Jilin Province Huinan Changlong Bio-pharmacy Co's Margin of Safety % (DCF Earnings Based) falls into.


FRA:JIL
81GF Score
Jilin Province Huinan Changlong Bio-pharmacy Co Ltd FRA:JIL
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Jilin Province Huinan Changlong Bio-pharmacy Co Margin of Safety % (DCF Earnings Based) Calculation

Jilin Province Huinan Changlong Bio-pharmacy Co's Margin of Safety % (DCF Earnings Based) for today is calculated as

Margin of Safety % (DCF Earnings Based)=(Intrinsic Value: DCF (Earnings Based)-Current Price)/Intrinsic Value: DCF (Earnings Based)
=(0.50-0.248)/0.50
=50.40 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The intrinsic value is calculated from the Discounted Earnings model with default parameters. The calculation method is the same as Discounted Cash Flow model except earnings are used in the calculation instead of free cash flow.

What does a Margin of Safety % (DCF Earnings Based) of 50.40% mean?
Jilin Province Huinan Changlong Bio-pharmacy Co (FRA:JIL) has a Margin of Safety % (DCF Earnings Based) of 50.40% as of Jul. 05, 2026. Margin of Safety % (DCF Earnings Based) is the percent difference between the current price and the intrinsic DCF Earnings price. View historical data on Jilin Province Huinan Changlong Bio-pharmacy Co.
Is Jilin Province Huinan Changlong Bio-pharmacy Co's Margin of Safety % (DCF Earnings Based) too high?
Jilin Province Huinan Changlong Bio-pharmacy Co's current Margin of Safety % (DCF Earnings Based) is 50.40%. Overall, Jilin Province Huinan Changlong Bio-pharmacy Co has a GF Score™ of 81/100, reflecting its overall financial health beyond just this single metric.
How does Jilin Province Huinan Changlong Bio-pharmacy Co's Margin of Safety % (DCF Earnings Based) compare to ZTS and UTHR?
Jilin Province Huinan Changlong Bio-pharmacy Co's Margin of Safety % (DCF Earnings Based) of 50.40% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Margin of Safety % (DCF Earnings Based) for a Drug Manufacturers company?
A good Margin of Safety % (DCF Earnings Based) depends on the Drug Manufacturers industry context. However, Margin of Safety % (DCF Earnings Based) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Margin of Safety % (DCF Earnings Based) mean?
A high Margin of Safety % (DCF Earnings Based) can signal that a stock is expensive relative to its fundamentals. Margin of Safety % (DCF Earnings Based) is the percent difference between the current price and the intrinsic DCF Earnings price. View historical data on Jilin Province Huinan Changlong Bio-pharmacy Co. Jilin Province Huinan Changlong Bio-pharmacy Co's current Margin of Safety % (DCF Earnings Based) is 50.40%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jilin Province Huinan Changlong Bio-pharmacy Co stock overvalued right now?
Jilin Province Huinan Changlong Bio-pharmacy Co (FRA:JIL) has a current Margin of Safety % (DCF Earnings Based) of 50.40%. The stock's GF Value™ is €0.18, compared to a current price of €0.25 — trading 37.8% above its estimated fair value. The current Margin of Safety % (DCF Earnings Based) is 50.40%. Jilin Province Huinan Changlong Bio-pharmacy Co's overall GF Score™ is 81/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Margin of Safety % (DCF Earnings Based) calculated?
Margin of Safety % (DCF Earnings Based) is calculated from a company's financial statements. For Jilin Province Huinan Changlong Bio-pharmacy Co (FRA:JIL), the current Margin of Safety % (DCF Earnings Based) is 50.40% as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Jilin Province Huinan Changlong Bio-pharmacy Co (FRA:JIL) Overvalued in 2026?

Based on GuruFocus' analysis, Jilin Province Huinan Changlong Bio-pharmacy Co stock appears to be overvalued. The current stock price of €0.25 is trading 37.8% above its estimated GF Value™ of €0.18.

Key valuation signals for FRA:JIL:

  • Margin of Safety % (DCF Earnings Based): 50.40%
  • GF Value™: €0.18 vs. price of €0.25 (37.8% above fair value)
  • GF Score™: 81/100 with 1 warning sign

No single metric tells the full story. See the FRA:JIL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Jilin Province Huinan Changlong Bio-pharmacy Co Business Description

Other Exchanges 08049:Hong Kong
Address 625 & 639 Nathan Road, Room 1101-2, 11th Floor, Office Tower Two, Grand Plaza, Mong kok, Kowloon, Hong Kong, HKG
Jilin Province Huinan Changlong Bio-pharmacy Co Ltd is principally engaged in the manufacture and distribution of Chinese medicines and pharmaceutical products in the PRC under the brand names of Changlong and Qing Tong. The company has only one business segment. It generates revenue from the Sales of Chinese medicines and pharmaceutical products. Geographically, it derives its entire revenue from the PRC.
81GF Score

Get the complete analysis for FRA:JIL

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.25
Price
€0.18
GF Value